Infection Management Test Offered in Key EU Markets
May 23 2018 Read 808 Times
A point of care (POC) test developed by Mologic for detecting infection in patients on peritoneal dialysis (PD), is to be distributed into key European markets including France, Germany, Italy, the Netherlands, Austria and Switzerland by medical technology companies Medisur and Peripal AG.
Widely accepted as a preferred method for managing end-stage renal disease, PD offers greater patient mobility and independence compared to other dialysis options, as well as being gentler to residual kidney function in early-stage disease. Recurring infection, or peritonitis, however, is a major issue for PD patients.
The PERiPLEX® test detects two critical biomarkers of infection in PD waste fluid using a lateral flow immunoassay system and provides a visual result within 10 minutes. A positive result can give PD patients warning of an infection, prompting them to contact their healthcare provider to initiate antibiotic therapy. Earlier identification of infection would enable pre-emptive use of available antibiotics, resulting in improved management of infection and prevention of infection-related damage to the peritoneal membrane.
Mark Davis, co-founder and CEO at Mologic commented: “Establishing a global distribution network is integral to Mologic’s product commercialisation strategy. With the appointment of distributors across Europe we will ensure PERiPLEX is available to more patients, giving them greater choice and the confidence to monitor their dialysis at home. Medisur and Peripal share our mission to improve the lives of patients by bringing diagnostics and treatment closer to home and with highly complementary product portfolios, we look forward to working together.”
The technology was developed following a collaborative project with Cardiff University Medical School, funded by the National Institute of Health Research (NIHR).
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Choosing the Optimum Plasma Spectrochemistry Technique for Measuring Elemental Impurities in Pharmaceuticals - Blue Jacaranda Seed Oil Analysed Using Comprehensive...
View all digital editions
Oct 17 2018 Moscow, Russia
Oct 17 2018 Strasbourg, France
Oct 17 2018 Kiev, Ukraine
Oct 23 2018 Frankfurt am Main, Germany
Oct 29 2018 Moscow, Russia